CrossrefScheda informativa
Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin
Gastroenterology Research · 2026-10 · 19 (5) · 295-301
DOI: 10.14740/gr2193 ↗Abstract
Abstract non disponibile.
EUVIMED